Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
BRFH - Barfresh Food Group Inc - Stock Price Chart
TickerBRFH [NASD]
CompanyBarfresh Food Group Inc
CountryUSA
IndustryBeverages - Non-Alcoholic
Market Cap21.64MEPS (ttm)-0.21
P/E-EPS this Y61.90%
Forward P/E-EPS next Y25.00%
PEG-EPS past 5Y23.29%
P/S2.66EPS next 5Y-
P/B8.47EPS Q/Q66.57%
Dividend-Sales Q/Q34.31%
Insider Own50.97%Inst Own11.45%
Insider Trans0.00%Inst Trans1.30%
Short Float0.94%EarningsFeb 29/a
Analyst Recom1.00Target Price3.00
Avg Volume8.03K52W Range1.00 - 2.39
Apr-02-24 12:53PM BRFH Stock Earnings: Barfresh Food Group Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
Mar-14-24 10:12AM 16 Largest Soda and Soft Drink Companies in The World (Insider Monkey)
Mar-06-24 08:15AM Barfresh Food Group, Inc. (NASDAQ:BRFH) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 04:05PM Barfresh Provides Fourth Quarter and Full Year 2023 Results and Business Update (GlobeNewswire) +5.62%
Feb-15-24 08:30AM Barfresh to Host Business Update Call on February 29, 2024 (GlobeNewswire)
Nov-01-23 11:50AM Barfresh Regains Compliance With Nasdaq Stockholders Equity Requirement (GlobeNewswire)
Oct-26-23 04:05PM Barfresh Provides Third Quarter 2023 Results and Business Update (GlobeNewswire) -5.98%
Oct-18-23 08:30AM Barfresh Highlights a Number of Recent Wins Within the Education Channel (GlobeNewswire)
Oct-12-23 08:30AM Barfresh to Host Business Update Call on October 26, 2023 (GlobeNewswire)
Aug-14-23 04:05PM Barfresh Provides Second Quarter 2023 Results and Expects to Achieve Positive Adjusted EBITDA for the Fourth Quarter of 2023 (GlobeNewswire)
SGBX - Safe & Green Holdings Corp - Stock Price Chart
TickerSGBX [NASD]
CompanySafe & Green Holdings Corp
CountryUSA
IndustryMetal Fabrication
Market Cap4.18MEPS (ttm)-1.15
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y56.27%
P/S0.22EPS next 5Y-
P/B0.67EPS Q/Q-23.26%
Dividend0.00%Sales Q/Q-3.99%
Insider Own34.90%Inst Own3.49%
Insider Trans0.00%Inst Trans3.11%
Short Float2.27%EarningsApr 15/a
Analyst Recom1.00Target Price2.81
Avg Volume715.25K52W Range0.14 - 1.35
Today 09:00AM Safe & Green Holdings Announces it Has Entered Into an Agreement to Produce Four Modular Electrical Distribution Centers as Part of a Multi-Unit Order for a Client Serving the Big Box Retailer Market (GlobeNewswire) +59.47%
Apr-24-24 08:30AM Safe & Green Holdings Corp. Announces Receipt of Nasdaq Notification (GlobeNewswire)
Apr-19-24 09:00AM Safe & Green Holdings Corp Provides Update on Its Audit and Planned 10-K Filing for the Year Ended December 31, 2023 (GlobeNewswire)
Apr-15-24 04:05PM Safe & Green Holdings Corp to Report Financial Results and File Its Form 10-K for the Year Ended December 31, 2023, on April 16, 2024 (GlobeNewswire)
Apr-11-24 09:00AM Safe & Green Holdings Enters Design/build Agreement With Talent Services Llc for the Design and Production of Eight Units Currently in Concept Stage (GlobeNewswire)
Apr-04-24 04:05PM Safe & Green Holdings Corp to Report Financial Results and File Its Form 10-K for the Year Ended December 31, 2023, on April 15, 2024 (GlobeNewswire)
Mar-21-24 08:30AM Safe & Green Holdings Expands Contract with Government Contractor to Refurbish 19 Container Modules for a Major U.S. Agency (GlobeNewswire)
Mar-19-24 08:30AM Safe & Green Holdings and Soldier on Sign Letter of Intent to Design, Build and Operate 800-Unit Supportive Housing Community for Veterans (GlobeNewswire) -5.86%
Feb-08-24 09:00AM Safe and Green Development Corporation Acquires XENE Real Estate AI Software (GlobeNewswire) -12.88%
Feb-06-24 08:30AM Safe & Green Holdings Announces it has Entered Into a Design Build Contract with Hostel Cubed to Produce First Modular Camping Cube for the California Coast (GlobeNewswire) -10.08%
ACON - Aclarion Inc - Stock Price Chart
TickerACON [NASD]
CompanyAclarion Inc
CountryUSA
IndustryHealth Information Services
Market Cap3.35MEPS (ttm)-8.62
P/E-EPS this Y87.07%
Forward P/E-EPS next Y54.39%
PEG-EPS past 5Y4.93%
P/S41.82EPS next 5Y-
P/B-EPS Q/Q4.89%
Dividend-Sales Q/Q-38.73%
Insider Own2.30%Inst Own0.54%
Insider Trans0.00%Inst Trans237.82%
Short Float0.95%Earnings-
Analyst Recom1.00Target Price1.50
Avg Volume1.44M52W Range0.27 - 25.60
Today 09:14AM Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain (GlobeNewswire) +62.47%
Apr-23-24 08:00AM Aclarion to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 (NewMediaWire)
Mar-04-24 08:00AM Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs (GlobeNewswire) +10.18%
Feb-27-24 03:22PM Aclarion Announces Closing of $3.0 Million Public Offering (GlobeNewswire)
Feb-26-24 09:15AM Aclarion Announces Pricing of $3.0 Million Public Offering (GlobeNewswire) -60.59%
08:42AM Why Is Aclarion (ACON) Stock Down 19% Today? (InvestorPlace)
Feb-05-24 08:00AM Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership (GlobeNewswire)
Jan-29-24 09:31AM Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion? (PR Newswire) -11.97%
09:17AM Why Is Aclarion (ACON) Stock Down 16% Today? (InvestorPlace)
Jan-26-24 07:58AM Why Is Aclarion (ACON) Stock Up 109% Today? (InvestorPlace) +52.28%
CYCC - Cyclacel Pharmaceuticals Inc - Stock Price Chart
TickerCYCC [NASD]
CompanyCyclacel Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap1.98MEPS (ttm)-27.02
P/E-EPS this Y49.98%
Forward P/E-EPS next Y-
PEG-EPS past 5Y32.13%
P/S4.71EPS next 5Y-
P/B2.62EPS Q/Q30.27%
Dividend-Sales Q/Q-
Insider Own8.89%Inst Own7.12%
Insider Trans7.27%Inst Trans-
Short Float3.20%EarningsMar 19/a
Analyst Recom1.00Target Price11.00
Avg Volume53.49K52W Range1.52 - 13.20
Apr-01-24 09:15AM Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer (GlobeNewswire)
Mar-20-24 10:05AM Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-19-24 08:53PM CYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q4 2023 (InvestorPlace) -6.37%
04:05PM Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-13-24 04:05PM Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-07-24 09:15AM Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 (GlobeNewswire) +5.06%
Mar-06-24 09:15AM Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit (GlobeNewswire) -8.49%
Feb-20-24 09:15AM Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference (GlobeNewswire)
Jan-30-24 09:15AM Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer (GlobeNewswire)
Jan-09-24 09:07AM Why Is Cyclacel Pharmaceuticals (CYCC) Stock Down 9% Today? (InvestorPlace)
JPSV - JPMorgan Active Small Cap Value ETF - Stock Price Chart
TickerJPSV [NYSE]
CompanyJPMorgan Active Small Cap Value ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Dividend & Fundamental
Index-
TagsU.S., equity, small-cap
Sector/Theme Region
Dividend1.10%Active/Passive
Total Holdings118AUM16.11M
Flows% 1M3.50%Flows% 3M9.15%
Flows% YTD11.17%Flows% 1Y
Return% 1Y16.93%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume0.86K52W Range45.45 - 56.25
PCSA - Processa Pharmaceuticals Inc - Stock Price Chart
TickerPCSA [NASD]
CompanyProcessa Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap6.41MEPS (ttm)-8.88
P/E-EPS this Y55.79%
Forward P/E-EPS next Y50.52%
PEG-EPS past 5Y9.70%
P/S-EPS next 5Y15.00%
P/B0.58EPS Q/Q88.48%
Dividend-Sales Q/Q-
Insider Own19.90%Inst Own1.96%
Insider Trans12.45%Inst Trans4.99%
Short Float8.28%Earnings-
Analyst Recom1.00Target Price44.00
Avg Volume1.60M52W Range1.40 - 18.00
TodayInitiated H.C. Wainwright Buy $8
Apr-11-24 08:00AM Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial (GlobeNewswire)
Mar-28-24 08:15AM Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference (GlobeNewswire)
Mar-25-24 08:15AM Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting (GlobeNewswire)
Feb-21-24 08:15AM Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference (GlobeNewswire) -8.47%
Feb-14-24 01:00PM Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference (GlobeNewswire)
Feb-06-24 08:30AM Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule (GlobeNewswire)
Feb-01-24 04:22PM Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering (GlobeNewswire)
Jan-26-24 09:04AM Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering (GlobeNewswire) -28.04%
Jan-25-24 02:40PM Why Is Processa Therapeutics (PCSA) Stock Up 90% Today? (InvestorPlace) +148.78%
08:30AM Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses (GlobeNewswire)
RYSE - Vest 10 Year Interest Rate Hedge ETF - Stock Price Chart
TickerRYSE [AMEX]
CompanyVest 10 Year Interest Rate Hedge ETF
CountryUSA
IndustryExchange Traded Fund
CategoryBonds - Treasury & Government
Index-
TagsU.S., futures, derivatives, hedge-rates
Sector/Theme Region
Dividend3.31%Active/Passive
Total Holdings4AUM2.56M
Flows% 1M-49.79%Flows% 3M-49.79%
Flows% YTD-49.79%Flows% 1Y
Return% 1Y23.63%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume0.77K52W Range21.26 - 27.65
OPTN - OptiNose Inc - Stock Price Chart
TickerOPTN [NASD, RUT]
CompanyOptiNose Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap114.84MEPS (ttm)-0.32
P/E-EPS this Y18.53%
Forward P/E-EPS next Y65.04%
PEG-EPS past 5Y34.78%
P/S1.62EPS next 5Y-
P/B-EPS Q/Q44.39%
Dividend-Sales Q/Q-4.75%
Insider Own28.62%Inst Own57.05%
Insider Trans-0.33%Inst Trans-0.27%
Short Float4.00%EarningsApr 25/b
Analyst Recom1.00Target Price3.75
Avg Volume621.06K52W Range0.86 - 2.10
Today 10:51AM Why Is OptiNose (OPTN) Stock Up 12% Today? (InvestorPlace) +10.17%
07:00AM Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million (GlobeNewswire)
Apr-04-24 04:01PM Optinose to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-15-24 03:34PM XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps (GlobeNewswire)
Mar-08-24 09:50AM OptiNose, Inc. (NASDAQ:OPTN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-07-24 09:41PM Q4 2023 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents)
01:54PM OptiNose Inc (OPTN) Reports Decline in 2023 Revenue Amidst Preparations for Potential XHANCE ... (GuruFocus.com)
12:52PM OPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023 (InvestorPlace)
08:15AM OptiNose (OPTN) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
07:33AM OptiNose: Q4 Earnings Snapshot (Associated Press Finance)
YYGH - YY Group Holding Limited Class A Ordinary Shares - Stock Price Chart
TickerYYGH [NASD]
CompanyYY Group Holding Limited Class A Ordinary Shares
CountrySingapore
IndustryPersonal Services
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q42.30%
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume592.60K52W Range2.04 - 4.70
Apr-24-24 11:39AM YY Group Announces Closing of Initial Public Offering (GlobeNewswire) -5.24%
Apr-19-24 04:56PM YY Group Announces Pricing of Initial Public Offering (GlobeNewswire)
AIRE - reAlpha Tech Corp. - Stock Price Chart
TickerAIRE [NASD]
CompanyreAlpha Tech Corp.
CountryUSA
IndustryReal Estate Services
Market Cap57.34MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.46EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own75.98%Inst Own1.06%
Insider Trans0.00%Inst Trans-
Short Float4.98%Earnings-
Analyst Recom-Target Price-
Avg Volume1.69M52W Range0.53 - 575.41
Today 08:12AM Why Is ReAlpha Tech (AIRE) Stock Up 43% Today? (InvestorPlace) +12.04%
Apr-24-24 11:36AM reAlpha Tech Corp. Launches Claire, Real Estate's First AI-powered, Zero-Commission Smart Buyer's Agent (Business Wire) +92.05%
Apr-19-24 04:30PM reAlpha Tech Corp. Announces Financial Results for the Quarter Ended March 31, 2024 (Business Wire)
Mar-13-24 08:43AM Why Is ReAlpha Tech (AIRE) Stock Down 15% Today? (InvestorPlace) -16.25%
Mar-12-24 04:05PM reAlpha Tech Corp. Announces Financial Results for the Transition Period ended December 31, 2023 and Provides Business Update (Business Wire) -10.61%
Feb-01-24 04:15PM reAlpha Tech Corp. Announces Executive Appointments (Business Wire)
Dec-18-23 01:04PM reAlpha to Acquire United Software Group to Boost AI Capabilities (Exec Edge) -7.26%
07:45AM reAlpha Tech Corp. Enters into Letter of Intent to Acquire United Software Group (Business Wire)
05:51AM AIRE Stock Earnings: ReAlpha Tech Corp Reported Results for Q2 2023 (InvestorPlace)
Dec-15-23 10:51PM AIRE Stock Earnings: ReAlpha Tech Corp Reported Results for Q2 2024 (InvestorPlace) +10.22%
123456⋯10⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.